{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:13:44Z","timestamp":1787786024908,"version":"build-2784847793"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.cca.2023.117460","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T20:50:27Z","timestamp":1687985427000},"page":"117460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Falsely decreased vancomycin caused by rheumatoid factor: A case report"],"prefix":"10.1016","volume":"548","author":[{"given":"Mai","family":"Elzieny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan A.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Sims","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl B.","family":"Lauter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin A.","family":"Carey-Ballough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1121-5344","authenticated-orcid":false,"given":"Qian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cca.2023.117460_b0005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jiph.2022.04.007","article-title":"Vancomycin Therapeutic Drug Monitoring (TDM) and Its Association with Clinical Outcomes: A Retrospective Cohort","volume":"15","author":"Al-Maqbali","year":"2022","journal-title":"J. Infect. Public Health"},{"issue":"8","key":"10.1016\/j.cca.2023.117460_b0010","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/cid\/ciz467","article-title":"60 Plus Years Later and We Are Still Trying to Learn How to Dose Vancomycin","volume":"70","author":"Rodvold","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"7\u20138","key":"10.1016\/j.cca.2023.117460_b0015","doi-asserted-by":"crossref","first-page":"717","DOI":"10.36290\/vnl.2018.098","article-title":"The Scottish model of vancomycin dosing and therapeutic drug monitoring improves both efficacy and safety of vancomycin therapy","volume":"64","author":"Zahalkova","year":"2018","journal-title":"Vnitr. Lek."},{"issue":"10","key":"10.1016\/j.cca.2023.117460_b0020","doi-asserted-by":"crossref","first-page":"e77169","DOI":"10.1371\/journal.pone.0077169","article-title":"Benefits of therapeutic drug monitoring of vancomycin: a systematic review and meta-analysis","volume":"8","author":"Ye","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.cca.2023.117460_b0025","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/phar.2376","volume":"40","author":"Rybak","year":"2020","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cca.2023.117460_b0030","unstructured":"MULTIGENT Vancomycin Assay [package insert]. Abbott Park; Illinois Abbott Laboratories. 2016."},{"issue":"3","key":"10.1016\/j.cca.2023.117460_b0035","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/FTD.0b013e318257335f","article-title":"The effect of paraproteins and rheumatoid factor on four commercial immunoassays for vancomycin: implications for laboratorians and other health care professionals","volume":"34","author":"LeGatt","year":"2012","journal-title":"Ther. Drug Monit."},{"issue":"3","key":"10.1016\/j.cca.2023.117460_b0040","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1373\/clinchem.2008.112946","article-title":"Two cases with unusual vancomycin measurements","volume":"55","author":"Simons","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2023.117460_b0045","doi-asserted-by":"crossref","first-page":"e00277","DOI":"10.1016\/j.plabm.2022.e00277","article-title":"A suspected case of falsely low digoxin and vancomycin concentrations caused by free kappa light chains with PETINIA method","volume":"30","author":"Tang","year":"2022","journal-title":"Pract. Lab. Med."},{"issue":"6","key":"10.1016\/j.cca.2023.117460_b0050","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0009-9120(99)00044-2","article-title":"High percentage of false positive cardiac troponin I results in patients with rheumatoid factor","volume":"32","author":"Krahn","year":"1999","journal-title":"Clin. Biochem."},{"issue":"5","key":"10.1016\/j.cca.2023.117460_b0055","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0168-8278(96)80229-7","article-title":"The presence of rheumatoid factor in sera from anti-HCV positive blood donors interferes with the detection of HCV-specific IgM. Trent HCV Study Group","volume":"25","author":"Stevenson","year":"1996","journal-title":"J. Hepatol."},{"issue":"6 Pt 1","key":"10.1016\/j.cca.2023.117460_b0060","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/clinchem\/43.6.957","article-title":"Misleading results from immunoassays of serum free thyroxine in the presence of rheumatoid factor","volume":"43","author":"Norden","year":"1997","journal-title":"Clin. Chem."},{"issue":"9","key":"10.1016\/j.cca.2023.117460_b0065","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s00296-021-04865-9","article-title":"Rheumatoid factor and falsely elevated results in commercial immunoassays: data from an early arthritis cohort","volume":"41","author":"Gehin","year":"2021","journal-title":"Rheumatol. Int."},{"issue":"6","key":"10.1016\/j.cca.2023.117460_b0070","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/ajcp\/112.6.753","article-title":"False-positive troponin I in the MEIA due to the presence of rheumatoid factors in serum. Elimination of this interference by using a polyclonal antisera against rheumatoid factors","volume":"112","author":"Dasgupta","year":"1999","journal-title":"Am. J. Clin. Pathol."},{"issue":"6","key":"10.1016\/j.cca.2023.117460_b0075","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/FTD.0b013e3181c01da1","article-title":"Rheumatoid factor interference in a tacrolimus immunoassay","volume":"31","author":"Barcelo Martin","year":"2009","journal-title":"Ther. Drug Monit."},{"issue":"4","key":"10.1016\/j.cca.2023.117460_b0080","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/labmed\/lmy014","article-title":"Interference by Rheumatoid Factor in Immunoglobulin M-Class Herpes Simplex Virus Types 1 + 2 Immunoassays","volume":"49","author":"Pan","year":"2018","journal-title":"Lab. Med."},{"key":"10.1016\/j.cca.2023.117460_b0085","first-page":"347","article-title":"Rheumatoid Factor interference in TSH assays","volume":"28","author":"Sl","year":"2012","journal-title":"Endocr. Abstr."},{"issue":"8","key":"10.1016\/j.cca.2023.117460_b0090","doi-asserted-by":"crossref","first-page":"e105304","DOI":"10.1371\/journal.pone.0105304","article-title":"Negative interference by rheumatoid factor of plasma B-type natriuretic peptide in chemiluminescent microparticle immunoassays","volume":"9","author":"Fan","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.cca.2023.117460_b0095","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1515\/CCLM.2006.205","article-title":"Rheumatoid factor interference in the determination of carbohydrate antigen 19\u20139 (CA 19\u20139)","volume":"44","author":"Berth","year":"2006","journal-title":"Clin. Chem. Lab. Med."},{"issue":"5","key":"10.1016\/j.cca.2023.117460_b0100","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/00365510510025818","article-title":"Human anti-immunoglobulin antibodies interfering in immunometric assays","volume":"65","author":"Bjerner","year":"2005","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"1\u20132","key":"10.1016\/j.cca.2023.117460_b0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0009-8981(99)00260-0","article-title":"Performance of the enhanced Abbott AxSYM cardiac troponin I reagent in patients with heterophilic antibodies","volume":"292","author":"Yeo","year":"2000","journal-title":"Clin. Chim. Acta"},{"issue":"7","key":"10.1016\/j.cca.2023.117460_b0110","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/clinchem\/34.7.1481","article-title":"The potency of immunoglobulin G fragments for inhibition of interference caused by anti-immunoglobulin antibodies in a monoclonal immunoradiometric assay for thyrotropin","volume":"34","author":"Csako","year":"1988","journal-title":"Clin. Chem."},{"issue":"7","key":"10.1016\/j.cca.2023.117460_b0115","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/clinchem\/45.7.942","article-title":"Human anti-animal antibody interferences in immunological assays","volume":"45","author":"Kricka","year":"1999","journal-title":"Clin. Chem."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123002620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123002620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:10:37Z","timestamp":1757862637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898123002620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":23,"alternative-id":["S0009898123002620"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2023.117460","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Falsely decreased vancomycin caused by rheumatoid factor: A case report","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2023.117460","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117460"}}